Michael Robert Martin
Chief Business Officer, Aurinia Pharmaceuticals Inc.
Companies
- Aurinia Pharmaceuticals Inc.Chief Business Officer Jan 4, 2021 to Mar 6, 20231
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Aurinia Pharmaceuticals Inc. AUPH259,162 shares2$4.3M at $16.51Mar 2, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Mar 2, 2023Granted 107,202 shares of Aurinia Pharmaceuticals Inc.2
- Nov 7, 2022Bought 30,000 shares at $5.16 of Aurinia Pharmaceuticals Inc.3
- Mar 2, 2022Sold 4,849 shares at $12.01 of Aurinia Pharmaceuticals Inc.4
- Mar 2, 2022Granted 8,500 shares of Aurinia Pharmaceuticals Inc.4
- Nov 11, 2021Sold 11,000 shares at $29.50 of Aurinia Pharmaceuticals Inc.5
- Nov 11, 2021Sold 29,000 shares at $28.82 of Aurinia Pharmaceuticals Inc.5
- Nov 11, 2021Exercised options 29,000 shares at $18.38 of Aurinia Pharmaceuticals Inc.5
- Nov 10, 2021Sold 10,000 shares at $30.55 of Aurinia Pharmaceuticals Inc.5
- Nov 10, 2021Sold 50,000 shares at $31.26 of Aurinia Pharmaceuticals Inc.5
- Nov 9, 2021Sold 50,000 shares at $30.17 of Aurinia Pharmaceuticals Inc.5
- Nov 1, 2021Sold 45,000 shares at $31.64 of Aurinia Pharmaceuticals Inc.6
- Nov 1, 2021Exercised options 45,000 shares at $3.20 of Aurinia Pharmaceuticals Inc.6
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Nov 9, 2022
- 4SEC EDGARForm 4 filed Mar 4, 2022
- 5SEC EDGARForm 4 filed Nov 12, 2021
- 6SEC EDGARForm 4 filed Nov 3, 2021